These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33656532)

  • 1. A 4 Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
    Li CW; Shi X; Ma B; Wang YL; Lu ZW; Liao T; Wang Y; Ji QH; Wei WJ
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3208-e3220. PubMed ID: 33656532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
    Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
    Xue Y; Li J; Lu X
    Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
    Wu P; Sun W; Zhang H
    Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
    Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
    Front Immunol; 2020; 11():1933. PubMed ID: 33072067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.
    Xu W; Li C; Ma B; Lu Z; Wang Y; Jiang H; Luo Y; Yang Y; Wang X; Liao T; Ji Q; Wang Y; Wei W
    Front Oncol; 2021; 11():641851. PubMed ID: 33996555
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
    Wang S; Cheng L; Jing F; Li G
    BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
    Qin R; Li C; Wang X; Zhong Z; Sun C
    Cancer Cell Int; 2021 Jul; 21(1):378. PubMed ID: 34266418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
    Chen W; Ou M; Tang D; Dai Y; Du W
    J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
    Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
    Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
    Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
    World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer.
    Ma B; Wen S; Luo Y; Zhang T; Yang Y; Shen C; Zhang Y; Ji Q; Qu N; Wang Y
    J Clin Endocrinol Metab; 2023 Jan; 108(2):368-384. PubMed ID: 36190930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an immune-related gene prognostic model for head and neck tumors.
    Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
    J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells.
    Wang X; Peng W; Li C; Qin R; Zhong Z; Sun C
    Cancer Cell Int; 2021 Apr; 21(1):231. PubMed ID: 33892730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immune-related gene signature predicts the 28-day mortality in patients with sepsis.
    Peng Y; Wu Q; Liu H; Zhang J; Han Q; Yin F; Wang L; Chen Q; Zhang F; Feng C; Zhu H
    Front Immunol; 2023; 14():1152117. PubMed ID: 37033939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.